Menu
Back to User profile » Dr Junru Chen
Papers published by Dr Junru Chen:
Multidisciplinary Team (MDT) Discussion Improves Overall Survival Outcomes for Metastatic Renal Cell Carcinoma Patients
Zeng Y, Zhu S, Wang Z, Chen J, Dai J, Liu Z, Sun G, Liang J, Zhang X, Wang Z, Zhao J, Ni Y, Yang J, Wang M, Wei Q, Li X, Chen N, Li Z, Wang X, Shen Y, Yao J, Huang R, Liu J, Cai D, Zeng H, Shen P
Journal of Multidisciplinary Healthcare 2023, 16:503-513
Published Date: 23 February 2023
Chronological Liquid Biopsy Reveals the Impact of Platinum-Based Chemotherapy on a Prostate Cancer Patient’s CDK12 Mutation: A Case Report
Zhu S, Bao Y, Zheng L, Zhao J, Chen Y, Huang R, Sun G, Zhao F, Zhang X, Liang J, Chen J, Wang Z, Ni Y, Chen N, Shen P, Zeng H
OncoTargets and Therapy 2022, 15:947-952
Published Date: 2 September 2022
Efficacy and Safety of Individualized Schedule of Sunitinib by Drug Monitoring in Patients with Metastatic Renal Cell Carcinoma
Zhu X, Zhang X, Sun G, Liu Z, Zhang H, Yang Y, Ni Y, Dai J, Zhu S, Chen J, Zhao J, Wang Z, Zeng H, Shen P
Cancer Management and Research 2021, 13:6833-6845
Published Date: 31 August 2021
The validation of the 2014 International Society of Urological Pathology (ISUP) grading system for patients with high-risk prostate cancer: a single-center retrospective study
Liu J, Zhao J, Zhang M, Chen N, Sun G, Yang Y, Zhang X, Chen J, Shen P, Shi M, Zeng H
Cancer Management and Research 2019, 11:6521-6529
Published Date: 12 July 2019
The effect of additional chemotherapy on high-risk prostate cancer: a systematic review and meta-analysis
Chen J, Zhang X, Sun G, Zhao J, Liu J, Zhao P, Dai J, Shen P, Zeng H
OncoTargets and Therapy 2018, 11:9061-9070
Published Date: 13 December 2018